|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.625 USD | +1.77% |
|
+4.99% | -39.83% |
Relay Therapeutics, Inc. reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was USD 0.253 million compared to USD 0.567 million a year ago. Net loss was USD 67.5 million compared to USD 67.46 million a year ago.
Basic loss per share from continuing operations was USD 0.56 compared to USD 0.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.83% | 864M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
RELAY THERAPEUTICS, INC. 
